Search Results
Showing Results for subretinal surgery
The EURETINA 2024 Congress, held in Barcelona from September 19-22, brought together leading experts in ophthalmology to share the latest research and innovative treatments for retinal diseases. Among the highlights were several late-breaking abstracts that showcased promising advances in therapeutics for conditions such as retinopathy of prematurity (ROP), diabetic retinopathy (DR) and age-related macular degeneration (AMD). These studies not only demonstrated the efficacy and safety of novel treatment options but also addressed critical unmet needs in reducing patient burden and improving long-term outcomes.
We are pleased to present the latest edition of touchREVIEWS in Ophthalmology. In this issue, we offer a series of engaging editorials, in-depth review articles and insightful original research highlighting some of the latest breakthroughs, innovations and practical insights in ...
Age-related macular degeneration (AMD) is a chronic deterioration and dysfunction of the outer retinal tissue and Bruch’s membrane (BrM). It is the leading cause of vision loss in people older than 60 years and is estimated to affect 288 million people ...
Age-related macular degeneration (AMD) is one of the main causes of irreversible vision loss in ageing populations worldwide.1 In 2019, the US recorded 1.49 million people aged 40 years or older with late-stage AMD, reflecting a crude prevalence rate of 0.94%.2 Geographic atrophy (GA), ...
Choroidal granuloma is a relatively rare manifestation of sarcoidosis. Cases of sarcoid granuloma may lack accompanying ocular inflammation and can mimic posterior segment tumours, leading to a delay in diagnosis and treatment. These lesions are typically steroid responsive,1 and quick ...
Corticosteroids are the best choice for treating various ocular conditions affecting the anterior and posterior segments of the eye.1 Currently, different routes are available for ocular administration of corticosteroids. Topical application to the eye is the route of choice when ...
Presbyopia is a progressive, age-related condition that reduces the eye’s ability to focus on near objects, due to gradual lens thickening and decline in its elasticity and accommodative capacity, and represents the first stage of the dysfunctional lens syndrome.1–3 ...
Primary myopia is a refraction anomaly of a non-accommodated eye with a spherical equivalent of -0.5 dioptres (D) or lower, often caused by an elongation of the visual axis.1 While visual axis length often varies between individuals and populations, a ‘...
Uveitis consists of a wide array of inflammatory disorders of the uveal tract and surrounding structures, which may lead to irreversible ocular damage and lasting visual impairment if not appropriately treated in a timely manner. As the fifth most common ...
Radiation retinopathy is a common and slowly progressive visual side effect of radiation therapy, such as brachytherapy, external beam radiotherapy, proton beam radiation, helium ion radiotherapy, and gamma knife radiotherapy for uveal melanoma and other intraocular or orbital cancers.1–6 Patients ...
Poor visualization is a common cause of failed retinal detachment surgery, both because of failure to identify and treat retinal breaks and because of residual vitreoretinal traction (see Figure 1). Cataract, especially cortical and posterior subcapsular cataract, limits crucial visualization of ...
Diplopia from comitant ocular deviations is a relatively common clinical presentation. On examination, the presence of a ductional deficit is suggestive of neuromuscular or neurogenic etiology. Without this deficit, the cause is usually attributed to the breakdown of previously well-controlled ...
Retinoblastoma is a primary intraocular cancer that develops in the eyes of children. The vast majority of retinoblastoma tumorigenesis is initiated by a mutation in the RB1 gene on chromosome 13q,1 which was the first tumor-suppressor gene described. Retinoblastoma is ...
Over the past 45 years, vitreoretinal surgery has evolved considerably. In 1972, Machemer et al. introduced the concept of pars plana vitrectomy with a 17-gauge vitreous cutter.1 Today, retinal surgeons have access to a wide variety of instruments as small as 27-gauge ...
One of the most important differential diagnoses in the pediatric retina population is retinoblastoma. A detailed history, good eye examination, good ultrasonography, and any other ancillary tests are essential for making the correct diagnosis. Retinoblastoma is the most common primary ...
Q. What is currently known about biomarkers of choroidal neovascularisation? The intravitreal anti-vascular endothelial growth factor (VEGF) approach has proven to be effective in the treatment of CNV and diabetic macular oedema. Many treatment regimens have been proposed to make ...
The use of anti-vascular endothelial growth factor (anti-VEGF) agents has revolutionised the treatment of exudative age-related macular degeneration (wet AMD). Multiple clinical studies have shown that beneficial functional and morphological responses can be obtained with either fixed dosing or as-needed (...
Glaucoma is the most common form of optic neuropathy and a leading cause of blindness worldwide.1 Currently, no treatment is available to reverse glaucomatous retinal ganglion cell (RGC) damage or vision loss. In clinic, glaucoma is diagnosed by optic disc ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
